Andrew Hillman

Senior paralegal and healthcare compliance expert witness based in Dallas, Texas. Retained through counsel on federal regulatory matters nationwide, across regulatory governance, internal investigations, and litigation support.

Expert witness subject areas: healthcare operations and hospital business practices, FDA enforcement patterns, Anti-Kickback Statute analysis, Stark Law structuring, and healthcare finance. Engagements are conducted under protective order.

Principal of Hillman Ventures, a Dallas private family office founded in 1995 that invests across frontier biotech for inflammation, damaged tissue, and tumor-based cancers, alongside healthcare compliance and FDA regulated science. Stewardship covers capital allocation, regulatory pathway selection, manufacturing partner selection, scientific advisory engagement, investor relations, and corporate governance.

Prior operating roles include co-founder of an FDA 510(k) registered orthopedic device company, a Texas Class A licensed pharmacy, a CLIA highly complex toxicology laboratory, a licensed pharmaceutical wholesale distributor, and a healthcare staffing and practice management company, each exited between 2020 and 2021. Founder of the Andrew Hillman Scholarship for Entrepreneurs and the Andrew Hillman Grant for Biotech.